Afinion Acr and Acr Control
Enzymatic Method, Creatinine. 510(k) K072409, from Axis-Shield Poc AS (Rodelokka, Oslo, NO). Product code JFY, class 2.
As of Nov 20, 2026, K072409 is an FDA 510(k) held by Axis-Shield Poc AS, substantially equivalent on Feb 12, 2008 after 169 days, with no recalls tied to it in FDA's recall database.
- Review time: 169 days
- Recalls: 0
- Cited as a predicate by: 2 devices
- Dca 2000 + Microalbumin/Creatinine AssayK963142 · Bayer Corp. · Sep 27, 1996
- Nova Allegro UACR Assay, Nova Allegro AnalyzerK221813 · Nova Biomedical Corporation · Nov 19, 2024
- Alere Afinion HbA1c and ACR on Afinion 2 analyzerK171650 · Abbott Rapid Diagnostics · Nov 21, 2017
- Qscheck UisacrK252619 · Qstag, Inc. · Feb 20, 2026
- Atellica CH Enzymatic Creatinine_3 (ECre3)K212223 · Siemens Healthcare Diagnostics, Inc. · Nov 24, 2021
- Yumizen C1200 Creatinine PAPK193649 · Horiba Abx SAS · May 10, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 27, 2007
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files